Cheap cancer can be cancer and hiv medicines! Governments preparing to reduce customs duty on 200 medicines

Prices for many serious illnesses including HIV, cancer, transplant drug and hematology may be cheap soon. A high-level committee stored by the government has recommended custom duty on about 200 significant drugs. This move can provide great relief to the patients suffering from many old diseases, including cancer.

Advertising

The report also recommended removal of customs duty on some global blocktster cancer duty. It includes Payambrolezumab (Brand Name Ketrudo), Osamemaminder Dructan (Brandum Nairtu). They are used in the treatment of lungs cancer, breast cancer and other serious cancer. The price of these drugs is up to millions of rupees, which causes it to be very expensive for ordinary patients.

Advertising

Who is involved in the committee?
The Drug Controller General of India (DCGI) formed this inter-department committee in August 2024. It is led United Nrug Controller R Chandraskhar and include senior officials of CMR, Pharmaceutical Department and Directorate General (DGS Directorate General (DGS).

Not only cancer is also transplant and dyagoustics
Panel’s recommendations are not limited to cancer drugs. This includes transplant medications, advanced diagnostic kits, blood medications of HIV and severe infection. Under this, a second category is created, including 5% of customs duty on 74 medicines. It includes hydroxy urea, which is used in the treatment of cancer and sickle cell anemia. The custom duty at the Anoxaparin is also recommended to reduce 5%, which is used in the treatment of blood and deep vein thrombosis.

Advertising

Patients of rare diseases can meet great relief
The report has a special section of the patients with the treatment of the treatment that reaches millions of times. The committee has recommended 56 to fully exempt from the customs duty on the customs duty. In addition involving Zolgenasma, Spinraza, Everidi, Seergem and Tariwer. The price of these drugs is worth crores of rupees, which is due to most patients in India.

Advertising

Recommend to make a standard committee
The report also recommended that a permanent inter-department committee should be constituted under the DGHS, which will promote such drugs and will send recommendations to the Finance Ministry.

(Disclaimer: Thoughts and investment advice provided by experts / brokerage firms on News 18, not websites and its management. News 18 users advise to advise with certified experts before making any investment decisions.)

Advertising

Source link

Leave a Comment